What is required to end the autism epidemic?
This talk will give an overview of the field and key areas that must be addressed in order to end autism. A full range of autism theories, environmental suspects, and potential biomarkers will be discussed. Peter will highlight key items and sequences he considers to be the most promising for autism recovery and prevention. The autism epidemic will end, one household at a time, as parents take action to protect their children and themselves from the primary environmental factors. (See description on the Autism One website)
Date/Time: Sat, 05/28/2016 - 9:30am - 10:30am
Track: End - Ending the epidemic
Fallon, Joan. “Could one of the most widely prescribed antibiotics amoxicillin/clavulanate “augmenting™” be a risk factor for autism?.” Medical hypotheses 64.2 (2005): 312-315.
Fujiwara, Takeo, et al. “Chemicals, nutrition, and autism spectrum disorder: a mini-review.” Frontiers in Neuroscience 10 (2016).
Boggess, Andrew, et al. "Mean serum-level of common organic pollutants is predictive of behavioral severity in children with autism spectrum disorders." Scientific Reports 6 (2016): 26185.
Samuel, Anthony, and Stephanie Seneff. “Glyphosate, pathways to modern diseases III: Manganese, neurological diseases, and associated pathologies.” Surgical neurology international 6 (2015).
Good, Peter. “Did acetaminophen provoke the autism epidemic.” Alter. Med. Rev 14 (2009): 364-372.
Autism and EMF: Published Papers (2004-2016)
Zaire, S., et al. “A Challenging Issue in the Etiology of Speech Problems: The Effect of Maternal Exposure to Electromagnetic Fields on Speech Problems in the Offspring.” Journal of biomedical physics & engineering 5.3 (2015): 151.
Herbert, Martha R., and Cindy Sage. “Autism and EMF? Plausibility of a pathophysiological link–Part I.” Pathophysiology 20.3 (2013): 191-209.
Wen, Ya, Mohamad J. Alshikho, and Martha R. Herbert. “Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling.” Plus one 11.4 (2016): e0153329.
Fern, F., et al. “Olfactory stem cells reveal MOCOS as a new player in autism spectrum disorders.” Molecular psychiatry (2015).
Robertson, Caroline E., Eva-Maria Ratai, and Nancy Kanwiyher. “Reduced GABAergic Action in the Autistic Brain.” Current Biology 26.1 (2016): 80-85.
Wong, Christine T., Joshua Wais, and Dorotea A. Crawford. “Prenatal exposure to common environmental factors affects brain lipids and increases risk of developing autism spectrum disorders.” European Journal of Neuroscience 42.10 (2015): 2742-2760.
Bumper, Elizabeth. “Can awareness of medical pathophysiology in autism lead to primary care autism prevention strategies.” North American Journal of Medicine and Science Jul 6.3 (2013): 135.
Naviaux, Robert K. “Metabolic features of the cell danger response.” Mitochondrion 16 (2014): 7-17.
Volk, Heather E., et al. “Residential proximity to freeways and autism in the CHARGE study.” Environmental health perspectives 119.6 (2011): 873.
Carlo, G. L., and T. J. Mariea. “Wireless radiation in the etiology and treatment of autism: clinical observations and mechanisms.” Journal of the Australasian College of Nutritional and Environmental Medicine 26.2 (2007): 3.
Packer, Pal, Joseph S. Beckman, and Lucas Liaudet. “Nitric oxide and peroxynitrite in health and disease.” Physiological reviews 87.1 (2007): 315-424.
Gialloreti, Leonardo Emberti, et al. “Reduction in Retinal Nerve Fiber Layer Thickness in Young Adults with Autism Spectrum Disorders.” Journal of autism and developmental disorders 44.4 (2014): 873-882.
Fallon, Joan M. "Method for identifying autistic individuals amenable to digestive enzyme therapy." U.S. Patent No. 8,008,036. 30 Aug. 2011.
Roberts, Timothy PL, et al. “MEG detection of delayed auditory evoked responses in autism spectrum disorders: towards an imaging biomarker for autism.” Autism Research 3.1 (2010): 8-18.